Observational studies indicate that
Aspergillus colonization and allergic bronchopulmonary aspergillosis (ABPA) in people with cystic fibrosis (CF) are associated with poorer lung health and increased disease severity. We performed a longitudinal observational cohort study to analyse long-term outcomes of
Aspergillus colonization and ABPA in children with CF. Anonymised UK CF Registry data from 2009 to 2019 for patients aged 8–17 years in 2009–2010 were collected. For the baseline cohort analysis, patients were classified based on the presence of
Aspergillus colonization and ABPA in 2009 and/or 2010. For the longitudinal analysis, patients were categorised according to annual
Aspergillus colonization and ABPA status. Comparisons made were (1)
Aspergillus positive vs. negative; (2) excluding those with ABPA:
Aspergillus positive vs. negative; and (3) ABPA positive vs. negative. Primary outcome was percentage predicted FEV
1 decline and secondary outcomes included BMI decline, mortality, lung transplant, and IV antibiotic use. Of the 1675 children, 263 had
Aspergillus colonization in the baseline cohort, 260 were diagnosed with ABPA, and 80 had both. Baseline cohort analysis showed significantly lower lung function (
p < 0.0001) and increased antibiotic treatment (
p < 0.001) in those with
Aspergillus colonization and in those with ABPA. Longitudinal analysis showed ABPA was associated with increased decline in lung function (
p < 0.00001) and BMI (
p < 0.00001).
Aspergillus colonization was associated with increased decline in BMI (
p = 0.005) but not lung function (
p = 0.30). ABPA was associated with increased decline in long-term lung function and BMI in children and young people with CF.
Aspergillus colonization was associated with lower lung function at baseline, but no increased rate of decline was observed long-term.
Full article
